Literature DB >> 8734453

Mutant insulin receptors in syndromes of insulin resistance.

A Krook1, S O'Rahilly.   

Abstract

To date, mutations of the insulin receptor remain the only well-established causes of severe insulin resistance. There is a broad correlation between the extent of impairment of signal transduction seen when the mutant receptors are expressed in vitro with the severity of the clinical phenotype. Thus leprechaunism, Rabson-Mendenhall syndrome and Type A insulin resistance appear to represent points on a continuum of severity of receptor dysfunction, rather than completely distinct syndromes. In other syndromes of insulin resistance, insulin receptor abnormalities remain the exception. However, functional studies of expressed naturally occurring insulin receptor mutations have acted as experiments of nature and greatly aided attempts to dissect the structure-function relationships of the receptor. The next few years will no doubt begin to reveal the contributions made by defects in the post-receptor signalling cascade to the syndromes of insulin resistance in man.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734453     DOI: 10.1016/s0950-351x(96)80330-2

Source DB:  PubMed          Journal:  Baillieres Clin Endocrinol Metab        ISSN: 0950-351X


  17 in total

Review 1.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 2.  Signaling pathways in insulin action: molecular targets of insulin resistance.

Authors:  J E Pessin; A R Saltiel
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

Review 3.  Insulin resistance.

Authors:  A J Krentz
Journal:  BMJ       Date:  1996-11-30

4.  Loss of mitochondrial protease ClpP protects mice from diet-induced obesity and insulin resistance.

Authors:  Shylesh Bhaskaran; Gavin Pharaoh; Rojina Ranjit; Ashley Murphy; Satoshi Matsuzaki; Binoj C Nair; Brittany Forbes; Suzana Gispert; Georg Auburger; Kenneth M Humphries; Michael Kinter; Timothy M Griffin; Sathyaseelan S Deepa
Journal:  EMBO Rep       Date:  2018-02-02       Impact factor: 8.807

5.  Description of the sphingolipid content and subspecies in the diabetic cornea.

Authors:  Shrestha Priyadarsini; Akhee Sarker-Nag; Jeremy Allegood; Charles Chalfant; Dimitrios Karamichos
Journal:  Curr Eye Res       Date:  2014-11-26       Impact factor: 2.424

6.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

Authors:  M Urbanek; R S Legro; D A Driscoll; R Azziz; D A Ehrmann; R J Norman; J F Strauss; R S Spielman; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 7.  Insulin signaling pathways and cardiac growth.

Authors:  Brian J DeBosch; Anthony J Muslin
Journal:  J Mol Cell Cardiol       Date:  2008-03-19       Impact factor: 5.000

8.  A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia.

Authors:  Satya Dash; Hiroyuki Sano; Justin J Rochford; Robert K Semple; Giles Yeo; Caroline S S Hyden; Maria A Soos; James Clark; Andrew Rodin; Claudia Langenberg; Celine Druet; Katherine A Fawcett; Y C Loraine Tung; Nicolas J Wareham; Inês Barroso; Gustav E Lienhard; Stephen O'Rahilly; David B Savage
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

Review 9.  Disordered lipid metabolism and the pathogenesis of insulin resistance.

Authors:  David B Savage; Kitt Falk Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

10.  Rabson-Mendenhall syndrome: medullary sponge kidney, a new component.

Authors:  Andrew M Harris; Bryan Hall; Vesna M Kriss; John L Fowlkes; Stefan G Kiessling
Journal:  Pediatr Nephrol       Date:  2007-09-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.